Yipu Capital
VC Fund
Yipu Capital is an investment firm
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yipu Capital invests in
Stages Yipu Capital invests in
Countries Yipu Capital invests in
Investment Focus
Industry
- Biotechnology 4 (44%)
- Biopharma 2 (22%)
- Health Care 2 (22%)
- Manufacturing 2 (22%)
- Semiconductor 2 (22%)
Stage
- Series B 4 (44%)
- Seed 1 (11%)
- Angel 1 (11%)
- Series A 1 (11%)
- Series C 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Lawnics Technology
|
Lawonics is a manufacturer specializing in high-end intelligent garden and power tools. The company focuses on research, development, and production of garden tools and intelligent equipment, providing smart solutions for various garden and life scenarios. It continuously improves product performance and user experience through advancedtechnologies like intelligent drive, precise calibration, and automatic charging. | Venture - Series Unknown / Apr 21, 2026 | |
Ronovo Surgical
|
Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery. | $28.3M / Series B / Aug 30, 2023 | |
Bio-Engine
|
Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields. | $43.1M / Series C / May 15, 2023 | |
Qixin Micro Semiconductor
|
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP,unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China. | Series B / Jul 07, 2022 | |
EVAS Intelligence
|
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui. | $28.3M / Seed / Mar 01, 2022 | |
|
EVAS Intelligence
|
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui. | $31.7M / Angel / Mar 01, 2022 | |
LakeShore Biopharma
|
Yisheng Biopharma is a global, fully integrated biopharmaceutical company engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using our novel PIKA® immunomodulating technology. PIKA technology augments both innate and adaptive immune responses through the TLR3, RIG-I and MDA5pathways. Products in clinical development include YS-ON-001 for the treatment of advanced solid tumors, YS-HBV-001 hepatitis B vaccine and the PIKA rabies vaccine for accelerated protection against rabies infection. | $130M / Series B / Feb 24, 2021 | |
Lepu Bio
|
Lepu Bio is a biotech company that develops a tumor immunology technology. It has established an industrial platform for target discovery, drug discovery, development, and production. The company's core products, PD-1, PD-L1, oncolytic virus, and multiple ADC products, have entered the clinical stage I-III. | Series A / Apr 01, 2020 | |
Transcenta
|
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta. | $100M / Series B / Jan 08, 2020 |
Co-Investors
Kington Capital
4 deals together
GAC Capital
3 deals together
CTC Capital
2 deals together
Lilly Asia Ventures
2 deals together
NRL Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yipu Capital invest in?
Yipu Capital invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Series B and Seed stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yipu Capital last invest?
The most recent investment recorded for Yipu Capital closed in Apr 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
